193 related articles for article (PubMed ID: 37019890)
1. Localized nuclear reaction breaks boron drug capsules loaded with immune adjuvants for cancer immunotherapy.
Shi Y; Guo Z; Fu Q; Shen X; Zhang Z; Sun W; Wang J; Sun J; Zhang Z; Liu T; Gu Z; Liu Z
Nat Commun; 2023 Apr; 14(1):1884. PubMed ID: 37019890
[TBL] [Abstract][Full Text] [Related]
2. PEGylated liposome encapsulating nido-carborane showed significant tumor suppression in boron neutron capture therapy (BNCT).
Lee W; Sarkar S; Ahn H; Kim JY; Lee YJ; Chang Y; Yoo J
Biochem Biophys Res Commun; 2020 Feb; 522(3):669-675. PubMed ID: 31787237
[TBL] [Abstract][Full Text] [Related]
3. The basis and advances in clinical application of boron neutron capture therapy.
He H; Li J; Jiang P; Tian S; Wang H; Fan R; Liu J; Yang Y; Liu Z; Wang J
Radiat Oncol; 2021 Nov; 16(1):216. PubMed ID: 34743756
[TBL] [Abstract][Full Text] [Related]
4. Boron neutron capture therapy of brain tumors: past history, current status, and future potential.
Barth RF; Soloway AH; Brugger RM
Cancer Invest; 1996; 14(6):534-50. PubMed ID: 8951358
[TBL] [Abstract][Full Text] [Related]
5. [The New Generation of Particle Therapy Focused on Boron Element (Boron Neutron Capture Therapy; BNCT) -The World's First Approved BNCT Drug].
Nakashima H
Yakugaku Zasshi; 2022; 142(2):155-164. PubMed ID: 35110452
[TBL] [Abstract][Full Text] [Related]
6. Accelerator-based boron neutron capture therapy for malignant glioma: a pilot neutron irradiation study using boron phenylalanine, sodium borocaptate and liposomal borocaptate with a heterotopic U87 glioblastoma model in SCID mice.
Zavjalov E; Zaboronok A; Kanygin V; Kasatova A; Kichigin A; Mukhamadiyarov R; Razumov I; Sycheva T; Mathis BJ; Maezono SEB; Matsumura A; Taskaev S
Int J Radiat Biol; 2020 Jul; 96(7):868-878. PubMed ID: 32339057
[No Abstract] [Full Text] [Related]
7. Advancements in Tumor Targeting Strategies for Boron Neutron Capture Therapy.
Luderer MJ; de la Puente P; Azab AK
Pharm Res; 2015 Sep; 32(9):2824-36. PubMed ID: 26033767
[TBL] [Abstract][Full Text] [Related]
8. Next generation of boron neutron capture therapy (BNCT) agents for cancer treatment.
Coghi P; Li J; Hosmane NS; Zhu Y
Med Res Rev; 2023 Sep; 43(5):1809-1830. PubMed ID: 37102375
[TBL] [Abstract][Full Text] [Related]
9. Boron containing macromolecules and nanovehicles as delivery agents for neutron capture therapy.
Wu G; Barth RF; Yang W; Lee RJ; Tjarks W; Backer MV; Backer JM
Anticancer Agents Med Chem; 2006 Mar; 6(2):167-84. PubMed ID: 16529539
[TBL] [Abstract][Full Text] [Related]
10. From Nuclear Reactor-Based to Proton Accelerator-Based Therapy: The Finnish Boron Neutron Capture Therapy Experience.
Porra L; Wendland L; Seppälä T; Koivunoro H; Revitzer H; Tervonen J; Kankaanranta L; Anttonen A; Tenhunen M; Joensuu H
Cancer Biother Radiopharm; 2023 Apr; 38(3):184-191. PubMed ID: 36269660
[TBL] [Abstract][Full Text] [Related]
11. Boronated DNA-binding compounds as potential agents for boron neutron capture therapy.
Crossley EL; Ziolkowski EJ; Coderre JA; Rendina LM
Mini Rev Med Chem; 2007 Mar; 7(3):303-13. PubMed ID: 17346220
[TBL] [Abstract][Full Text] [Related]
12. Boron neutron capture therapy of brain tumors: an emerging therapeutic modality.
Barth RF; Soloway AH; Goodman JH; Gahbauer RA; Gupta N; Blue TE; Yang W; Tjarks W
Neurosurgery; 1999 Mar; 44(3):433-50; discussion 450-1. PubMed ID: 10069580
[TBL] [Abstract][Full Text] [Related]
13. Application of drug delivery system to boron neutron capture therapy for cancer.
Yanagië H; Ogata A; Sugiyama H; Eriguchi M; Takamoto S; Takahashi H
Expert Opin Drug Deliv; 2008 Apr; 5(4):427-43. PubMed ID: 18426384
[TBL] [Abstract][Full Text] [Related]
14. Influence of Neutron Sources and 10B Concentration on Boron Neutron Capture Therapy for Shallow and Deeper Non-small Cell Lung Cancer.
Yu H; Tang X; Shu D; Liu Y; Geng C; Gong C; Hang S; Chen D
Health Phys; 2017 Mar; 112(3):258-265. PubMed ID: 28121726
[TBL] [Abstract][Full Text] [Related]
15. A Model for Estimating Dose-Rate Effects on Cell-Killing of Human Melanoma after Boron Neutron Capture Therapy.
Matsuya Y; Fukunaga H; Omura M; Date H
Cells; 2020 Apr; 9(5):. PubMed ID: 32365916
[TBL] [Abstract][Full Text] [Related]
16. Boron delivery agents for neutron capture therapy of cancer.
Barth RF; Mi P; Yang W
Cancer Commun (Lond); 2018 Jun; 38(1):35. PubMed ID: 29914561
[TBL] [Abstract][Full Text] [Related]
17. Boron neutron capture therapy using dodecaborated albumin conjugates with maleimide is effective in a rat glioma model.
Kashiwagi H; Kawabata S; Yoshimura K; Fukuo Y; Kanemitsu T; Takeuchi K; Hiramatsu R; Nishimura K; Kawai K; Takata T; Tanaka H; Watanabe T; Suzuki M; Miyatake SI; Nakamura H; Wanibuchi M
Invest New Drugs; 2022 Apr; 40(2):255-264. PubMed ID: 34816337
[TBL] [Abstract][Full Text] [Related]
18. Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory.
Chadha M; Capala J; Coderre JA; Elowitz EH; Iwai J; Joel DD; Liu HB; Wielopolski L; Chanana AD
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):829-34. PubMed ID: 9531367
[TBL] [Abstract][Full Text] [Related]
19. [Neutrons in Clinical Practice: BNCT].
Tanaka H
Igaku Butsuri; 2022; 42(3):143-148. PubMed ID: 36184424
[TBL] [Abstract][Full Text] [Related]
20. Electroporation optimizes the uptake of boron-10 by tumor for boron neutron capture therapy (BNCT) mediated by GB-10: a boron biodistribution study in the hamster cheek pouch oral cancer model.
Garabalino MA; Olaiz N; Portu A; Saint Martin G; Thorp SI; Pozzi ECC; Curotto P; Itoiz ME; Monti Hughes A; Colombo LL; Nigg DW; Trivillin VA; Marshall G; Schwint AE
Radiat Environ Biophys; 2019 Aug; 58(3):455-467. PubMed ID: 31123853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
